01-08-2004
Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group
Published in: Investigational New Drugs | Issue 3/2004
Login to get access01-08-2004
Published in: Investigational New Drugs | Issue 3/2004
Login to get access